z-logo
open-access-imgOpen Access
Evaluation of apremilast in chronic pruritus of unknown origin: A proof‐of‐concept, phase 2a, open‐label, single‐arm clinical trial
Author(s) -
Clark Marie,
Wang Fang,
Bodet Nancy D.,
Kim Brian S.
Publication year - 2020
Publication title -
health science reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.462
H-Index - 7
ISSN - 2398-8835
DOI - 10.1002/hsr2.154
Subject(s) - apremilast , medicine , dermatology , clinical trial , etiology , open label , thalidomide , psoriasis , psoriatic arthritis , multiple myeloma

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom